← Back to Search

EyeTurn App for Strabismus

N/A
Waitlist Available
Led By Kevin E Houston, OD
Research Sponsored by Massachusetts Eye and Ear Infirmary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is developing a smartphone app to detect eye misalignment in children. The app uses the phone's camera to take pictures and measure alignment by analyzing light reflections on the eyes. Early detection can help prevent long-term vision problems.

Eligible Conditions
  • Strabismus
  • Crossed Eyes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Strabismus angle with the app compared to ground truth and gold standard tests
Secondary study objectives
Perceived Value Survey
Robustness
Test-Retest repeatability of the app

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: EyeTurn AppExperimental Treatment1 Intervention
All participants will have their eye alignment measured with both the experimental device (EyeTurn app) and the clinical gold standard tests or ground truth (simulated strabismus gaze angles).

Find a Location

Who is running the clinical trial?

Massachusetts Eye and Ear InfirmaryLead Sponsor
108 Previous Clinical Trials
12,844 Total Patients Enrolled
1 Trials studying Strabismus
22 Patients Enrolled for Strabismus
National Eye Institute (NEI)NIH
553 Previous Clinical Trials
1,407,119 Total Patients Enrolled
12 Trials studying Strabismus
23,248 Patients Enrolled for Strabismus
Kevin E Houston, ODPrincipal InvestigatorMassachusetts Eye and Ear
2 Previous Clinical Trials
51 Total Patients Enrolled
~25 spots leftby Nov 2025